Literature DB >> 3300367

Degradation of endogenous heptadecapeptide gastrin by endopeptidase 24.11 in the pig.

D M Power, N Bunnett, A J Turner, R Dimaline.   

Abstract

Hydrolysis of heptadecapeptide gastrin (G-17) by endopeptidase 24.11 (EC 3.4.24.11) was studied in vivo and in vitro in the pig. Ion exchange chromatography and radioimmunoassay with three region-specific antisera were used to identify the products of porcine G-17 degradation. Incubation of antral extracts with pure endopeptidase 24.11 resulted in a substantial loss of intact G-17: 80% C-terminal immunoreactivity was lost in 60 min. This hydrolysis was completely inhibited by phosphoramidon, which is a specific inhibitor of endopeptidase 24.11. In antral extracts G-17 accounted for greater than 95% of total C-terminal immunoreactivity, compared with less than 60% C-terminal immunoreactivity in the gastric venous outflow; shorter C-terminal forms comprised the major part of the remaining immunoreactivity. After infusion of phosphoramidon, the concentration of intact G-17 was increased, and there was a corresponding reduction in the concentration of other C-terminal immunoreactive fragments. We conclude that endopeptidase 24.11 degrades G-17 in vitro and in vivo and may be responsible for the generation of C-terminal fragments from G-17 after secretion from the porcine antral mucosa.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3300367     DOI: 10.1152/ajpgi.1987.253.1.G33

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  4 in total

1.  Recombinant human enkephalinase (neutral endopeptidase) prevents cough induced by tachykinins in awake guinea pigs.

Authors:  H Kohrogi; J A Nadel; B Malfroy; C Gorman; R Bridenbaugh; J S Patton; D B Borson
Journal:  J Clin Invest       Date:  1989-09       Impact factor: 14.808

2.  Expression of CD10/neutral endopeptidase in normal and malignant tissues of the human stomach and colon.

Authors:  Y Sato; F Itoh; Y Hinoda; Y Ohe; N Nakagawa; R Ueda; A Yachi; K Imai
Journal:  J Gastroenterol       Date:  1996-02       Impact factor: 7.527

3.  Sacubitril/valsartan increases postprandial gastrin and cholecystokinin in plasma.

Authors:  Ulrik Ø Andersen; Dijana Terzic; Nicolai Jacob Wewer Albrechtsen; Peter Dall Mark; Peter Plomgaard; Jens F Rehfeld; Finn Gustafsson; Jens P Goetze
Journal:  Endocr Connect       Date:  2020-05       Impact factor: 3.335

4.  Impact of clinically tested NEP/ACE inhibitors on tumor uptake of [(111)In-DOTA]MG11-first estimates for clinical translation.

Authors:  Aikaterini Kaloudi; Berthold A Nock; Emmanouil Lymperis; Roelf Valkema; Eric P Krenning; Marion de Jong; Theodosia Maina
Journal:  EJNMMI Res       Date:  2016-02-16       Impact factor: 3.138

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.